Intra-operative Perforation: a Risk Factor for Prognosis of Low Rectal Cancer After Abdominoperineal Resection

Overview

Journal Med Oncol

Publisher Springer

Specialty Oncology

Date 2014 Apr 25

PMID 24760343

Citations 1

Authors

Xing-Mao Zhang

Jun-Li Dai

Sheng-Hui Ma

Jian-Wei Liang

Zheng Wang

Jian-Jun Bi

Zhi-Xiang Zhou

Affiliations

Soon will be listed here.

Abstract

This study was designed to explore the influence of intra-operative perforation on prognosis of low rectal cancer after APR and to investigate the risk factors of perforation. Perforation is not scarce during the procedure of abdominoperineal resection (APR). There is no consensus on perforation rate and related risk factor for APR. Data of 925 patients who received APR for low rectal cancer between January 2000 and August 2008 were reviewed. The intra-operative perforation rate was 7.4 % (68/925). The recurrence rate was 28.6 % in patients with intra-operative perforation compared with 6.8 % in patients with no perforation (P < 0.001); 5-year survival rate in patients with perforation was 41.4 and 66.3 % in patients with no perforation. Univariate analysis showed that intra-operative perforation affected recurrence rate and survival significantly (P < 0.001, P < 0.001); multivariate analysis revealed that intra-operative perforation was an independent prognostic factors for recurrence (RR: 3.087, P < 0.001), while not for survival (RR: 1.331, P = 0.051). Patients aged more than 70 years, T3 tumor and treated by general surgeon had higher perforation rate (P = 0.001, P = 0.004, P = 0.008). Intra-operative perforation affected the prognosis of low rectal cancer after APR significantly. Elderly patient aged more than 70 years, T3 tumor and general surgeon who performed operation were three risk factors of increased perforation rate.

Citing Articles

Critical and Challenging Issues in the Surgical Management of Low-Lying Rectal Cancer.

Nacion A, Park Y, Yang S, Kim N Yonsei Med J. 2018; 59(6):703-716.

PMID: 29978607 PMC: 6037599. DOI: 10.3349/ymj.2018.59.6.703.

References

Bernstein T, Endreseth B, Romundstad P, Wibe A . Circumferential resection margin as a prognostic factor in rectal cancer. Br J Surg. 2009; 96(11):1348-57. DOI: 10.1002/bjs.6739. View

Bulow S, Christensen I, Iversen L, Harling H . Intra-operative perforation is an important predictor of local recurrence and impaired survival after abdominoperineal resection for rectal cancer. Colorectal Dis. 2010; 13(11):1256-64. DOI: 10.1111/j.1463-1318.2010.02459.x. View

Marr R, Birbeck K, Garvican J, Macklin C, Tiffin N, Parsons W . The modern abdominoperineal excision: the next challenge after total mesorectal excision. Ann Surg. 2005; 242(1):74-82. PMC: 1357707. DOI: 10.1097/01.sla.0000167926.60908.15. View

Jorgren F, Johansson R, Damber L, Lindmark G . Oncological outcome after incidental perforation in radical rectal cancer surgery. Int J Colorectal Dis. 2010; 25(6):731-40. DOI: 10.1007/s00384-010-0930-9. View

Wibe A, Moller B, Norstein J, Carlsen E, Wiig J, Heald R . A national strategic change in treatment policy for rectal cancer--implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum. 2002; 45(7):857-66. DOI: 10.1007/s10350-004-6317-7. View

Bebenek M . Abdominosacral amputation of the rectum for low rectal cancers: ten years of experience. Ann Surg Oncol. 2009; 16(8):2211-7. DOI: 10.1245/s10434-009-0517-2. View

Eriksen M, Wibe A, Syse A, Haffner J, Wiig J . Inadvertent perforation during rectal cancer resection in Norway. Br J Surg. 2004; 91(2):210-6. DOI: 10.1002/bjs.4390. View

West N, Anderin C, Smith K, Holm T, Quirke P . Multicentre experience with extralevator abdominoperineal excision for low rectal cancer. Br J Surg. 2010; 97(4):588-99. DOI: 10.1002/bjs.6916. View

West N, Finan P, Anderin C, Lindholm J, Holm T, Quirke P . Evidence of the oncologic superiority of cylindrical abdominoperineal excision for low rectal cancer. J Clin Oncol. 2008; 26(21):3517-22. DOI: 10.1200/JCO.2007.14.5961. View

10.

Heald R, Husband E, Ryall R . The mesorectum in rectal cancer surgery--the clue to pelvic recurrence?. Br J Surg. 1982; 69(10):613-6. DOI: 10.1002/bjs.1800691019. View

11.

Kapiteijn E, Marijnen C, Nagtegaal I, Putter H, Steup W, Wiggers T . Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001; 345(9):638-46. DOI: 10.1056/NEJMoa010580. View

12.

Wibe A, Syse A, Andersen E, Tretli S, Myrvold H, Soreide O . Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resection. Dis Colon Rectum. 2004; 47(1):48-58. DOI: 10.1007/s10350-003-0012-y. View

13.

Skipper D, Cooper A, Marston J, Taylor I . Exfoliated cells and in vitro growth in colorectal cancer. Br J Surg. 1987; 74(11):1049-52. DOI: 10.1002/bjs.1800741130. View

14.

Yu H, Peng H, He X, Zhao R . Comparison of short- and long-term outcomes after extralevator abdominoperineal excision and standard abdominoperineal excision for rectal cancer: a systematic review and meta-analysis. Int J Colorectal Dis. 2013; 29(2):183-91. DOI: 10.1007/s00384-013-1793-7. View

15.

Umpleby H, Fermor B, Symes M, Williamson R . Viability of exfoliated colorectal carcinoma cells. Br J Surg. 1984; 71(9):659-63. DOI: 10.1002/bjs.1800710902. View

16.

Stelzner S, Koehler C, Stelzer J, Sims A, Witzigmann H . Extended abdominoperineal excision vs. standard abdominoperineal excision in rectal cancer--a systematic overview. Int J Colorectal Dis. 2011; 26(10):1227-40. DOI: 10.1007/s00384-011-1235-3. View

17.

Nagtegaal I, van de Velde C, Marijnen C, van Krieken J, Quirke P . Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol. 2005; 23(36):9257-64. DOI: 10.1200/JCO.2005.02.9231. View

18.

How P, Shihab O, Tekkis P, Brown G, Quirke P, Heald R . A systematic review of cancer related patient outcomes after anterior resection and abdominoperineal excision for rectal cancer in the total mesorectal excision era. Surg Oncol. 2011; 20(4):e149-55. DOI: 10.1016/j.suronc.2011.05.001. View